Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2023 Mar 28

PMID 36974507

Authors

Rebecca A Abelman

Thuy Trang J Nguyen

Yifei Ma

Peter Bacchetti

Geralyn Messerlian

Audrey L French

Anjali Sharma

Howard Minkoff

Michael Plankey

Carl Grunfeld

Phyllis C Tien

Affiliations

Soon will be listed here.

Abstract

Background: Women are at risk for weight gain during the transition to menopause, but few have examined the contribution of menopause to weight gain in women with human immunodeficiency virus (WWH).

Methods: From 2000 to 2013, participants (621 WWH; 218 without HIV [WWOH]) from the Women's Interagency HIV Study were categorized by menopausal phase using serial measures of anti-Müllerian hormone (AMH). Multivariable linear mixed models examined the association of menopausal phase with body mass index (BMI) and waist circumference (WC) trajectory, stratified by HIV status.

Results: In models controlled for chronologic age, the estimated effects (95% confidence interval) of menopausal phase on annual rate of BMI change across early perimenopause, late perimenopause, and menopause, respectively, compared to premenopause were -0.55% (-.80 to -.30), -0.29% (-.61 to .03), and -0.67% (-1.12 to -.20) in WWH, whereas estimated effects were 0.43% (-.01 to .87) and 0.15% (-.42 to .71) across early and late perimenopause, respectively, and -0.40% (-1.24 to .45) across menopause in WWOH. The estimated effects on rate of WC change were negative across early perimenopause (-0.21% [-.44 to .03]) and menopause (-0.12% [-.5 to .26]) and positive across late perimenopause (0.18% [-.10 to .45]) in WWH, and positive across all 3 menopausal phases in WWOH, but these effects were not statistically significant.

Conclusions: In WWH, the menopausal transition was associated with BMI and WC trajectories that were mostly in a negative direction and opposite from WWOH after adjusting for age, suggesting that HIV blunts weight gain during the menopausal transition.

References

Welsh P, Smith K, Nelson S . A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Hum Reprod. 2014; 29(5):1035-41. DOI: 10.1093/humrep/deu036. View

Seillet C, Laffont S, Tremollieres F, Rouquie N, Ribot C, Arnal J . The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling. Blood. 2011; 119(2):454-64. DOI: 10.1182/blood-2011-08-371831. View

Herrin M, Tate J, Akgun K, Butt A, Crothers K, Freiberg M . Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals. J Acquir Immune Defic Syndr. 2016; 73(2):228-36. PMC: 5023454. DOI: 10.1097/QAI.0000000000001071. View

de Waal R, Cohen K, Maartens G . Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS One. 2013; 8(5):e63623. PMC: 3665842. DOI: 10.1371/journal.pone.0063623. View

Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R . Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012; 97(4):1159-68. PMC: 3319184. DOI: 10.1210/jc.2011-3362. View

Imai K, Sutton M, Mdodo R, Del Rio C . HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy. Obstet Gynecol Int. 2014; 2013:340309. PMC: 3880754. DOI: 10.1155/2013/340309. View

Das B, Dobrowolski C, Luttge B, Valadkhan S, Chomont N, Johnston R . Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir. Proc Natl Acad Sci U S A. 2018; 115(33):E7795-E7804. PMC: 6099847. DOI: 10.1073/pnas.1803468115. View

Grunfeld C, Saag M, Cofrancesco Jr J, Lewis C, Kronmal R, Heymsfield S . Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS. 2010; 24(11):1717-26. PMC: 3309711. DOI: 10.1097/QAD.0b013e32833ac7a2. View

Siedner M, Zanni M, Tracy R, Kwon D, Tsai A, Kakuhire B . Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda. J Infect Dis. 2018; 218(6):922-926. PMC: 6093434. DOI: 10.1093/infdis/jiy244. View

10.

Sax P, Erlandson K, Lake J, McComsey G, Orkin C, Esser S . Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. Clin Infect Dis. 2019; 71(6):1379-1389. PMC: 7486849. DOI: 10.1093/cid/ciz999. View

11.

Rojas J, Lonca M, Imaz A, Estrada V, Asensi V, Miralles C . Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir. HIV Med. 2016; 17(5):340-9. DOI: 10.1111/hiv.12314. View

12.

Lake J, Trevillyan J . Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV. Curr Opin HIV AIDS. 2021; 16(3):148-151. DOI: 10.1097/COH.0000000000000680. View

13.

Szotek E, Narasipura S, Al-Harthi L . 17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription. Virology. 2013; 443(2):375-83. PMC: 3722310. DOI: 10.1016/j.virol.2013.05.027. View

14.

Donato G, Fuchs S, Oppermann K, Bastos C, Spritzer P . Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006; 13(2):280-5. DOI: 10.1097/01.gme.0000177907.32634.ae. View

15.

Fasshauer M, Bluher M . Adipokines in health and disease. Trends Pharmacol Sci. 2015; 36(7):461-70. DOI: 10.1016/j.tips.2015.04.014. View

16.

Hunt P, Lee S, Siedner M . Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection. J Infect Dis. 2016; 214 Suppl 2:S44-50. PMC: 5021241. DOI: 10.1093/infdis/jiw275. View

17.

Scherzer R, Greenblatt R, Merhi Z, Kassaye S, Lambert-Messerlian G, Maki P . Use of antimüllerian hormone to predict the menopausal transition in HIV-infected women. Am J Obstet Gynecol. 2016; 216(1):46.e1-46.e11. PMC: 5182170. DOI: 10.1016/j.ajog.2016.07.048. View

18.

Greendale G, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K . Changes in body composition and weight during the menopause transition. JCI Insight. 2019; 4(5). PMC: 6483504. DOI: 10.1172/jci.insight.124865. View

19.

DSouza G, Bhondoekhan F, Benning L, Margolick J, Adedimeji A, Adimora A . Characteristics of the MACS/WIHS Combined Cohort Study: Opportunities for Research on Aging With HIV in the Longest US Observational Study of HIV. Am J Epidemiol. 2021; 190(8):1457-1475. PMC: 8484936. DOI: 10.1093/aje/kwab050. View

20.

Achhra A, Sabin C, Ryom L, Hatleberg C, Antonella dAminio M, De Wit S . Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort Analysis. J Acquir Immune Defic Syndr. 2018; 78(5):579-588. DOI: 10.1097/QAI.0000000000001722. View